However, differences in EIF4G2 expression became statistically meaningful when patients were stratified by tumor grade; there was significantly lower OS and RFS in patients with Grade 2 tumors that expressed low levels of EIF4G2 (Fig. 1E, F). Here, EIF4G2 is linked to neoplasm.